2882035-56-3
2882035-56-3
Chemical Structure
PCSK9-IN-11
- CAS. Nr.: 2882035-56-3
- Formula:C16H17ClFN5O3
- Molecular Weight:381.79
IUPAC Name: 7-(3-chloro-2-fluorobenzyl)-8-((2-hydroxyethyl)amino)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
InChIKey: UVWKWCCDYSHPMZ-UHFFFAOYSA-N
SMILES: O=C(N1C)N(C)C2=C(N(CC3=CC=CC(Cl)=C3F)C(NCCO)=N2)C1=O
Biological Activity: PCSK9-IN-11 (compound 5r) is a potent and orally active PCSK9 inhibitor. PCSK9-IN-11 exhibits PCSK9 transcriptional inhibitory activity in HepG2 cells, with an IC50 of 5.7 μM. PCSK9-IN-11 increases LDL receptor (LDLR) protein level. PCSK9-IN-11 can be used for atherosclerosis research[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
PCSK9-IN-11 | 99.30% | PCSK9-IN-11 (compound 5r) is a potent and orally active PCSK9 inhibitor. PCSK9-IN-11 exhibits PCSK9 transcriptional inhibitory activity in HepG2 cells, with an IC50 of 5.7 μM. PCSK9-IN-11 increases LDL receptor (LDLR) protein level. PCSK9-IN-11 can be used for atherosclerosis research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.76
HY-1619397030B-C5 -
Similarity Score 0.70
HY-152221PCSK9-IN-10 -
Similarity Score 0.62
HY-162618PSB-KK1445 -
Similarity Score 0.61
HY-162617PSB-KK1415 -
Similarity Score 0.60
HY-170572PB01 -
Similarity Score 0.60
HY-147907Adenosine receptor inhibitor 1 -
Similarity Score 0.57
HY-100164RSDZ-MKS 492 (Standard) -
Similarity Score 0.55
HY-147908Adenosine receptor inhibitor 2 -
Similarity Score 0.54
HY-169520VEGFR/PDGFR-IN-1 -
Explore the MedChemAI to find more analogs
